XML 14 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Dec. 31, 2015
Net Cash flows used from operating activities:        
Net loss $ (45,563,617) $ (26,945,976) $ (44,265,276) $ (10,047,036)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization expenses 1,044 181,134 182,037 298,797
Issuance of common stock for services 10,000 203,055
Change in fair value of digital currencies (2,671) (8,665) (8,665) 3,442
Fair value adjustments for warrant liabilities 40,338,368 8,183,196 25,266,593 (482,666)
Fair value adjustments for convertible notes 16,849,071 3,245,896 (2,096,700) 3,748
Fair value adjustments for derivative liability shortfall of shares 7,401,321 14,915,419
Gain on extinguishment of debt (15,866,197) 2,859,338 (837,369)
Loss from lease termination 177,389
Impairment loss related to investment 2,250,000 2,250,000 254,433
Impairment loss on fixed assests 240,853 236,585
Loss on sale of fixed assets 11,002 1,530
Loss on extinguishment of debt 2,859,338    
Loss on issuance of Preferred C 2,809,497    
Liquidated damages 693,000 1,621,750 3,102,750
Stock based compensation 6,383,772
Issuance of derivative liability warrants for services 100,000
Loss on issuance of Units 250,000 250,000 1,050,911
Loss on issuance of convertible notes and warrants 952,060
Inducement expenses 58,380
Changes in operating assets and liabilities:        
Digital currencies 2,868 25,501 25,502 (4,438)
Accounts receivable
Prepaid expenses and other current assets (20,378) (394) 8,902 37,752
Accounts payable and accrued expenses (387,129) 260,499    
Accounts payable 140,233 391,258
Net cash used in operating activities (958,755) (674,545) (828,459) (796,532)
Net cash used in investing activities:        
Purchase of property and equipment (1,484) (19,238) (14,582) (553,069)
Sale of property and equipment, net 57,335 66,807 8,293
Refund of lease deposit 310,889 335,000 (332,070)
Investments at cost (2,350,000)
Net cash (used in) provided by investing activities (1,484) 348,986 387,225 (3,226,846)
Net cash provided by financing activities:        
Net proceeds from exercise of warrant 91,766 91,765
Net proceeds from May fund raising 925,114    
Proceeds from issuance of convertible notes, net 100,000 320,002 1,362,500
Payment to settle the investor loan (54,000)      
Change in overdraft 9,258    
Common stock repurchase (2,500)
Net proceeds from issuance of Private Placement Units 2,695,500
Net proceeds from issuance of Private Placement Units from related party 50,000
Proceeds from short term loan 45,000
Proceeds from short term loan from related party 20,000
Payment on short term loan to related party (27,990)
Net cash provided by financing activities 871,114 201,024 411,767 4,142,510
Net decrease in cash (89,125) (124,535) (29,467) 119,132
Cash, beginning of period 95,068 124,535 124,535 5,403
Cash, end of period 5,943 95,068 124,535
Supplemental disclosure of non-cash financing and investing activities:        
Cashless warrant exercise 11,638,566 212,230 3,537 56,744
Fractional shares adjusted for reverse split 4
FN Anti-Dilution Issuance of Common Stock 14,517
Conversion of Series B Preferred Stock 76,525
Management Redemption 400 5,409,571
Conversion of convertible notes to common stock (4,208,546)
Settlement of notes and warrants 90,168,290
Preferred converted to Common Stock (383)
Preferred issued for conversion of notes 1,160
Debt settlement from sale of fix assets 22,200 22,200
Reclassification between convertible note and derivative liabilities 92,601 92,601
Conversion of Series C Convertible Preferred to common stock 2,200
Issuance of common stock for fixed assets purchases 48,626
Conversion of accounts payable to common stock 246,924
Issuance of common stock for investment $ 154,433